ArticleScientific reports2025
Risk factors for pterygium recurrence based on a retrospective study of 196 patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Gene Expression Signatures Associated with Pterygium Recurrence.Journal of clinical medicine · 2026Article
- Recurrence rate, time to recurrence, and associated factors after primary pterygium excision with conjunctival-limbal autograft: a prospective cohort study.BMC ophthalmology · 2026Article
- The evaluation of hemogram-related systemic inflammatory markers in pterygium recurrence.BMC ophthalmology · 2026Article
- Analysis of the application effect of an automated eye position fixation training device in patients undergoing pterygium surgery: a two-year follow-up randomized controlled trial.Frontiers in medicine · 2026Article
- PentagonalInternational journal of ophthalmology · 2026Article
- Characteristics and risk factors of recurrent pterygium underwent excision combined with limbal conjunctival autograft in southern rural China.Frontiers in medicine · 2026Article
- Association of serum complement C3 level with disease severity in primary pterygium.Frontiers in medicine · 2025Article
- Exploring the Contribution of Interleukin-12A Genetic Polymorphisms to Pterygium Risk.In vivo (Athens, Greece)Article
- Exploring the Genetic Role of Matrix Metalloproteinase-13 Variants in Pterygium Risk.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Pterygium is considered as important clinical problem due to its special characteristics such as high incidence, multi-factorial disorder and high recurrence rate. The purpose of this study is to identify the postoperative recurrence rate of pterygium and examine the association between systemic inflammation and the type of pterygium and pterygium recurrence. From January 2017 to January 2018, a total of 196 pterygium patients who received surgery were included in this study. Demographic and clinical data were available and extracted from the ongoing clinic records and interviews. Kaplan-Meier analysis was used to evaluate recurrence over time, univariate analysis and logistic regression analysis were applied to identify the variables that may affect the recurrence after pterygium surgery. All enrolled patients were routinely followed up for average of 24.78 ± 6.08 months, among them, 15 patients (7.65%) presented with recurrence following resection surgery. Multivariate analysis showed that recurrence was significantly associated with neutrophil to lymphocyte ratio (NLR) (odds ratio [OR] 4.35, 95% confidence interval [CI], 1.14-16.61, P = 0.03) and pterygium grade (OR: 6.08, 95% CI, 1.52-24.31, P = 0.01) . The postoperative recurrence rate of recurrent pterygium was 7.65%. The preoperative NLR and pterygium grade were significantly associated with recurrence. This study brings potential future benefits to patients selection outcome prediction and improving long-term care strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.